New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Men with faults in their BRCA2 gene are at higher risk of aggressive prostate cancer.
Since the 1980s, PSA tests have been used for the diagnosis and follow-up of prostate cancer. However, its use as a screening test for prostate cancer remains controversial.
A family physician and public health researcher explains why he isn’t getting a prostate cancer test in Movember or at any time in the near future.